Maik Schuler

Pfizer (United States)

Publishes on Carcinogens and Genotoxicity Assessment, DNA Repair Mechanisms, Effects and risks of endocrine disrupting chemicals. 64 papers and 1.5k citations.

PubIndex Score17Top 83% · seniorHow it's scored

64Publications

1.5kTotal Citations

First publication: 1996First senior author: 1999

Carcinogens and Genotoxicity Assessment DNA Repair Mechanisms Effects and risks of endocrine disrupting chemicals Genetically Modified Organisms Research Water Treatment and Disinfection

Top publicationsby citations

Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing

V. Thybaud, Errol Zeiger, Marilyn J. Aardema et al.|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2006

Cited by 131

Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells

David A. Eastmond, D.S. Rupa, Maik Schuler|Mutation Research Letters|1995

Cited by 119

Improvement of in vivo genotoxicity assessment: Combination of acute tests and integration into standard toxicity testing

Andreas Rothfuß, Hans‐Jörg Martus, Masamitu Honma et al.|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2010

Cited by 106

Synthesis, Molecular Editing, and Biological Assessment of the Potent Cytotoxin Leiodermatolide

Damien Mailhol, Alois Fürstner, Jens Willwacher et al.|Journal of the American Chemical Society|2014

Cited by 93

A critical evaluation of centromeric labeling to distinguish micronuclei induced by chromosomal loss and breakage in vitro

Maik Schuler, David A. Eastmond, D.S. Rupa|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|1997

Cited by 89